Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chememan PCLBKK:CMAN +1.43%71 ROE % is 24.63% as of Mar. 2026, which is 160% above its 10-year median of 9.46. GuruFocus rates BKK:CMAN with a GF Score™ of 71/100 and a GF Value™ of ฿2.18 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,584 Chemicals companies, Chememan PCL ranks better than 85.73% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Chememan PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿688 Mil. Chememan PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿2,792 Mil. Therefore, Chememan PCL's annualized ROE % for the quarter that ended in Mar. 2026 was 24.63%.
The historical rank and industry rank for Chememan PCL's ROE % or its related term are showing as below:
BKK:CMAN'
s ROE % Range Over the Past 10 Years
Min: -5.81 Med: 9.46 Max: 15.61
Current: 14.96
During the past 11 years, Chememan PCL's highest ROE % was 15.61%. The lowest was -5.81%. And the median was 9.46%.
BKK:CMAN's ROE % is ranked better than 85.73% of 1584
companies
in the Chemicals industry
Industry Median: 5.25
vs BKK:CMAN: 14.96
Chememan PCL (BKK:CMAN) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Chememan PCL ROE % Related Terms
Chememan PCL ROE % Historical Data
* Premium members only.
The historical data trend for Chememan PCL's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Chememan PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chememan PCL ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Chememan PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Chememan PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Chememan PCL (BKK:CMAN) has a ROE % of 24.63% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Chememan PCL and its competitors. This is 160% above median its historical median of 9.46. According to the industry distribution chart, Chememan PCL ranks #226 out of 1584 companies in the Chemicals industry, placing it in the top 14.3%.
Is Chememan PCL's ROE % too high?
Chememan PCL's current ROE % of 24.63% is 160% above median its 10-year median of 9.46. The Chemicals industry median ROE % is 5.25. Chememan PCL's value of 24.63% is 369.1% above this industry median. Based on the distribution chart, Chememan PCL ranks #226 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Chememan PCL has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chememan PCL's ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Chememan PCL ranks #226 out of 1584 companies for ROE %. This places Chememan PCL in the top 14% of its industry — outperforming the majority of peers. The industry median ROE % is 5.25. Chememan PCL's value of 24.63% is 369.1% above this benchmark. While the company's 10-year median is 9.46 vs. the industry median of 5.25, Chememan PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.25, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chememan PCL's current ROE % of 24.63% is 369.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Chememan PCL and its competitors. For the Chemicals industry, the median ROE % is 5.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chememan PCL's current ROE % is 24.63%, which is 160% above median its own 10-year median of 9.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chememan PCL stock overvalued right now?
Based on GuruFocus' analysis, Chememan PCL (BKK:CMAN) is currently considered Modestly Overvalued. The stock's GF Value™ is ฿2.18, compared to a current price of ฿2.84 — trading 30.3% above its estimated fair value. The current ROE % is 24.63%, which is 160% above median its 10-year median of 9.46 and 369.1% above the Chemicals industry median of 5.25. Chememan PCL's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Chememan PCL (BKK:CMAN), the current ROE % is 24.63% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chememan PCL (BKK:CMAN) Overvalued in 2026?
Based on GuruFocus' analysis, Chememan PCL stock appears to be overvalued.
The current stock price of ฿2.84 is trading 30.3% above its estimated GF Value™ of ฿2.18.
GuruFocus considers Chememan PCL to be Modestly Overvalued.
Key valuation signals for BKK:CMAN:
ROE %: 24.63% (160% above median its 10-year median of 9.46)
GF Value™: ฿2.18 vs. price of ฿2.84 (30.3% above fair value)
Industry Position: 369.1% above the Chemicals median (#226 of 1584)
No single metric tells the full story. See the BKK:CMAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chememan PCL is engaged in the manufacture and distribution of mineral lime products. The company transforms natural resources into basic and specialty chemicals and synthetic products. Its product offerings include quicklime (Calcium Oxide, CaO), hydrated lime (Calcium Hydroxide, Ca(OH)2), as well as chemical grade and construction limestone (Calcium Carbonate, CaCO3). The group's business operations involve two geographic segments: the company, which is incorporated in Thailand, manufactures and distributes minerals and chemicals; and the subsidiaries, which are incorporated overseas, manufacture and distribute minerals and chemicals. The majority of the group's revenue is derived from its business in Thailand, and the rest from overseas markets.
71GF Score
Get the complete analysis for BKK:CMAN
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMAN has been successfully added to your 
